These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38677091)

  • 41. Regulation and Therapeutic Application of Long non-Coding RNA in Tumor Angiogenesis.
    Zhang S; Xia Y; Chen W; Dong H; Cui B; Liu C; Liu Z; Wang F; Du J
    Technol Cancer Res Treat; 2024; 23():15330338241273239. PubMed ID: 39110070
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Capturing functional long non-coding RNAs through integrating large-scale causal relations from gene perturbation experiments.
    Xu J; Shi A; Long Z; Xu L; Liao G; Deng C; Yan M; Xie A; Luo T; Huang J; Xiao Y; Li X
    EBioMedicine; 2018 Sep; 35():369-380. PubMed ID: 30177244
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Emerging role of exosome-derived long non-coding RNAs in tumor microenvironment.
    Sun Z; Yang S; Zhou Q; Wang G; Song J; Li Z; Zhang Z; Xu J; Xia K; Chang Y; Liu J; Yuan W
    Mol Cancer; 2018 Apr; 17(1):82. PubMed ID: 29678180
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Angiogenic lncRNAs: A potential therapeutic target for ischaemic heart disease.
    Xu ZM; Huang F; Huang WQ
    Life Sci; 2018 Oct; 211():157-171. PubMed ID: 30219334
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oncogenic long noncoding RNA landscape in breast cancer.
    Xu S; Kong D; Chen Q; Ping Y; Pang D
    Mol Cancer; 2017 Jul; 16(1):129. PubMed ID: 28738804
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Noncoding RNAs in Tumor Angiogenesis.
    Khorshidi A; Dhaliwal P; Yang BB
    Adv Exp Med Biol; 2016; 927():217-41. PubMed ID: 27376737
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pan-cancer characterization of immune-related lncRNAs identifies potential oncogenic biomarkers.
    Li Y; Jiang T; Zhou W; Li J; Li X; Wang Q; Jin X; Yin J; Chen L; Zhang Y; Xu J; Li X
    Nat Commun; 2020 Feb; 11(1):1000. PubMed ID: 32081859
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long non-coding RNAs: An emerging powerhouse in the battle between life and death of tumor cells.
    Xiong XD; Ren X; Cai MY; Yang JW; Liu X; Yang JM
    Drug Resist Updat; 2016 May; 26():28-42. PubMed ID: 27180308
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Distinct RNA transcriptome patterns are potentially associated with angiogenesis in Tie2-expressing monocytes.
    Wang X; Dai Z; Wu X; Wang K; Wang X
    Gene; 2016 Apr; 580(1):1-7. PubMed ID: 26748243
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mechanisms of lncRNA/microRNA interactions in angiogenesis.
    Zhao Z; Sun W; Guo Z; Zhang J; Yu H; Liu B
    Life Sci; 2020 Aug; 254():116900. PubMed ID: 31786194
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The hallmarks of cancer: a long non-coding RNA point of view.
    Gutschner T; Diederichs S
    RNA Biol; 2012 Jun; 9(6):703-19. PubMed ID: 22664915
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long noncoding RNA: an emerging paradigm of cancer research.
    Qiu MT; Hu JW; Yin R; Xu L
    Tumour Biol; 2013 Apr; 34(2):613-20. PubMed ID: 23359273
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CCAT1: a pivotal oncogenic long non-coding RNA in human cancers.
    Xin Y; Li Z; Shen J; Chan MT; Wu WK
    Cell Prolif; 2016 Jun; 49(3):255-60. PubMed ID: 27134049
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long noncoding RNAs and cancer, an overview.
    Camacho CV; Choudhari R; Gadad SS
    Steroids; 2018 May; 133():93-95. PubMed ID: 29317255
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metastasis Associated Lung Adenocarcinoma Transcript 1: An update on expression pattern and functions in carcinogenesis.
    Ghafouri-Fard S; Ashrafi Hafez A; Taheri M
    Exp Mol Pathol; 2020 Feb; 112():104330. PubMed ID: 31712117
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Non-coding RNAs targeting notch signaling pathway in cancer: From proliferation to cancer therapy resistance.
    Hashemi M; Hasani S; Hajimazdarany S; Mirmazloomi SR; Makvandy S; Zabihi A; Goldoost Y; Gholinia N; Kakavand A; Tavakolpournegari A; Salimimoghadam S; Nabavi N; Zarrabi A; Taheriazam A; Entezari M; Hushmandi K
    Int J Biol Macromol; 2022 Dec; 222(Pt A):1151-1167. PubMed ID: 36191781
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context.
    Chiu HS; Somvanshi S; Patel E; Chen TW; Singh VP; Zorman B; Patil SL; Pan Y; Chatterjee SS; ; Sood AK; Gunaratne PH; Sumazin P
    Cell Rep; 2018 Apr; 23(1):297-312.e12. PubMed ID: 29617668
    [TBL] [Abstract][Full Text] [Related]  

  • 58. LncRNA MALAT1 signaling pathway and clinical applications in overcome on cancers metastasis.
    Mazarei M; Shahabi Rabori V; Ghasemi N; Salehi M; Rayatpisheh N; Jahangiri N; Saberiyan M
    Clin Exp Med; 2023 Dec; 23(8):4457-4472. PubMed ID: 37695391
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An emerging link between lncRNAs and cancer sex dimorphism.
    Naciri I; Andrade-Ludena MD; Yang Y; Kong M; Sun S
    Hum Genet; 2024 Jul; 143(7):831-842. PubMed ID: 38095719
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The landscape of long non-coding RNAs in tumor stroma.
    Uddin MN; Wang X
    Life Sci; 2021 Jan; 264():118725. PubMed ID: 33166593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.